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Abstract
Recombinant adenovirus has been used extensively to express foreign genes because of its high infection
eﬃciency and its ability to infect a broad spectrum of cell-types. In this review, we describe these advantages
and how it works by using a recombinant adenovirus to study the NS2 of Hepatitis C virus (HCV) and focal
adhesion kinase(FAK)- related non-kinase(FRNK). Taken the research we have done together recombinant
adenovirus demonstrates a very useful vector for transferring genes of interest from the outside.
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Recombinant adenovirus has been used extensively
for transferring foreign genes because of several
unique advantages. For example, it can infect most
types of cells. High titer of virus and high expression
level of foreign genes were easy to be obtained
[1] . The most commonly used adenovirus is serotype
5 human adenovirus with a linear and double
stranded DNA genome [1] . Currently the engineered
adenoviral vectors have made the expression of
foreign genes much more convenient as compared
to the previous adenoviral vectors. The most critical
improvement is that the recombination process
happens in E.coli instead of mammalian cells, which
have low recombination eﬃciency and needs plaque
puriﬁcation [1] . The engineered adenoviral vectors
include a GFP marker that can easy identify the
eﬃciency of transfection and infection. These unique
advantages of newly engineered adenovirus have
been applied to most of our previous research.
An important non-structural gene of HCV genome
is ns2. NS2 was shown to inhibit several promoters in
hepatic and nonhepatic cell lines, such as promoters
that control the expression of CMV and SV40 [2] .NS2
can block apoptosis by inhibiting the release of
cytochrome C [3] . In order to study the function of
NS2 in the HCV life cycle, a system that can express a
high level of NS2 in hepatic cell lines, such as HepG2,
would be needed. From our previous experience,
the level of expression of foreign genes in HepG2
cells is usually low with traditional methods, such
as lipofectin transfection. Instead we constructed a
recombinant adenovirus that can express ns2 with a
GFP marker. The titer of this recombinant adenovirus
can be high up to 109 PFU/ml after propagation in 293
cells [4] . The infection eﬃciency of this recombinant
adenovirus in HepG2 cells can be up to 90% [4] .
This high infection eﬃciency contributes to the high
expression of ns2 in HepG2 cells [4] . The GFP marker
carried by recombinant adenovirus also make it easy
to observe the antiviral eﬀect of natural product
such as dioscin [5] .
FAK (focal adhesion kinase), also referred to
as cell adhesion kinase (CAK)-Β, related adhesion
focal tyrosine kinase (RAFTK) or calcium-dependent
protein tyrosine kinase (CADTK) [6] , belongs to
the members of the FAK family of non-receptor
protein tyrosine kinases. FAK has been shown to
be closely related with cell adhesion, migration
and growth regulation. Increased FAK expression
has been correlated with increased cancer cell
motility, invasiveness and proliferation [6] . FRNK is
located at the C-terminal region of FAK. It doesn't
have kinase activity or the autophosphorylation site
Tyr-397 that is seen in FAK. FRNK is a dominant-
negative inhibitor of FAK by competitive inhibition
[7] . Recently, Cao et al., not only constructed
a recombinant adenovirus that expresses murine
FRNK [8] that can inhibit tumor cell motility and
invasion but also a recombinant adenovirus that
expresses human FRNK(hFRNK) [9] . The titer of
these two recombinant adenovirus can be high
up to 1012 PFU/ml, which facilitates the following
research on the study of the function of FRNK.
Colo320, a colonic carcinoma cell line, is diﬃcult to
undergo transfection with lipofectin. Cao et al., used
a constructed adenovirus that expresses FRNK to
infect the colo320 and studied the eﬀect of FRNK on
the phosphorylated 190RhoGAP and RhoA Activity
in colo320WT colorectal cells. Cao et al., found
that hFRNK can inhibit expression of phosphorylated
p190RhoGAP and enhance RhoA activity in the cells
stimulated with Gastrin17 [10] , which activates
beta-catenin/Tcf-4 signaling in Colo320WT cells,
thereby leading to an over-expression of c-myc and
cyclin D1. This mechanism probably works with
hFRNK blocking FAK phosphorylation and the FAK
2pathway [11] . Cao et al., also found that adenovirus
carrying hFRNK can inhibit abnormal distribution
of E-cadherin and beta-catenin in the gastrin17-
stimulated cells. The mechanism probably works
similarly with hFRNK dephosphorylating FAK and
blocking the FAK pathway [12] .
Generally, recombinant adenovirus is an eﬃcient
system that is characterized by high eﬃciency
infection and high expression level of foreign genes.
Furthermore, the important and critical advantage is
that the high eﬃciency infection is cell independent,
which enables us to study the eﬀect of interested
genes in most of type of cells without the previous
constraint. The high expression level of foreign genes
also can allow us to save cost on the carrier that
transfers the foreign DNA into cells such as lipofectin.
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